Tissue repair, contraction, and the myofibroblast

Area of Science:

• Cell Biology
• Tissue Engineering
• Pathology

Background:

• The myofibroblast, initially identified in wound granulation tissue, is now recognized in various normal and pathological conditions.
• It represents an intermediate cell type between fibroblasts and smooth muscle cells.
• Myofibroblast presence is associated with mechanical force development and fibrotic diseases.

Purpose of the Study:

• To elucidate the differentiation process of myofibroblasts.
• To identify key regulators of myofibroblast differentiation.
• To highlight the role of myofibroblasts in connective tissue remodeling and disease.

Main Methods:

• Electron microscopy was used for initial identification.
• Characterization of cellular components, including cytoplasmic actins (beta, gamma, alpha-smooth muscle actin).
• Investigation of regulatory factors such as transforming growth factor-beta1 and fibronectin splice variants.

Main Results:

• Fibroblast to myofibroblast transition involves protomyofibroblasts and differentiated myofibroblasts.
• Stress fibers evolve to contain specific actin isoforms.
• Myofibroblast differentiation is regulated by TGF-beta1, ED-A fibronectin, and mechanical tension.

Conclusions:

• Myofibroblasts are central to wound healing and fibrosis.
• Targeting myofibroblasts offers potential therapeutic strategies for fibrotic conditions.
• Further research into myofibroblast biology can improve treatments for hypertrophic scars and organ fibrosis.